Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,712 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade.
Di Nitto C, Ravazza D, Gilardoni E, Look T, Sun M, Prodi E, Moisoiu V, Pellegrino C, Manz MG, Puca E, Weller M, Weiss T, Neri D, De Luca R. Di Nitto C, et al. Among authors: weller m. J Immunother Cancer. 2024 Aug 13;12(8):e008504. doi: 10.1136/jitc-2023-008504. J Immunother Cancer. 2024. PMID: 39142716 Free PMC article.
Tripokin: A multi-specific immunocytokine for cancer immunotherapy.
Prodi E, Corbellari R, Ghezzi L, Ciambellotti S, Catastini JE, Rappuoli M, Rotta G, Sakic I, Weiss T, Weller M, Pellegrino C, Manz MG, Neri D, De Luca R. Prodi E, et al. Among authors: weller m. Int J Cancer. 2025 Jan 1;156(1):216-228. doi: 10.1002/ijc.35145. Epub 2024 Aug 23. Int J Cancer. 2025. PMID: 39177452
A T-cell antigen atlas for meningioma: novel options for immunotherapy.
Medici G, Freudenmann LK, Velz J, Wang SS, Kapolou K, Paramasivam N, Mühlenbruch L, Kowalewski DJ, Vasella F, Bilich T, Frey BM, Dubbelaar ML, Patterson AB, Zeitlberger AM, Silginer M, Roth P, Weiss T, Wirsching HG, Krayenbühl N, Bozinov O, Regli L, Rammensee HG, Rushing EJ, Sahm F, Walz JS, Weller M, Neidert MC. Medici G, et al. Among authors: weller m. Acta Neuropathol. 2023 Aug;146(2):173-190. doi: 10.1007/s00401-023-02605-w. Epub 2023 Jun 27. Acta Neuropathol. 2023. PMID: 37368072 Free PMC article.
Comparison of clinically available dynamic susceptibility contrast post processing software to differentiate progression from pseudoprogression in post-treatment high grade glioma.
Nierobisch N, Ludovichetti R, Kadali K, Fierstra J, Hüllner M, Michels L, Achangwa NR, Alcaide-Leon P, Weller M, Kulcsar Z, Hainc N. Nierobisch N, et al. Among authors: weller m. Eur J Radiol. 2023 Oct;167:111076. doi: 10.1016/j.ejrad.2023.111076. Epub 2023 Sep 1. Eur J Radiol. 2023. PMID: 37666072 Free article.
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.
de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB, Young RJ, Huang RY, Ellingson BM, Capper D, Phillips JJ, Halasz LM, Shih HA, Rudà R, Lim-Fat MJ, Blumenthal DT, Weller M, Arakawa Y, Whittle JR, Ducray F, Reardon DA, Bi WL, Minniti G, Rahman R, Hervey-Jumper S, Chang SM, Wen PY. de la Fuente MI, et al. Among authors: weller m. Neuro Oncol. 2024 Dec 25:noae259. doi: 10.1093/neuonc/noae259. Online ahead of print. Neuro Oncol. 2024. PMID: 39723472
Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].
Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A, Maccari M, Cerretti G, Ius T, Minniti G, Idbaih A, Sanai N, Weller M, Preusser M, Simonelli M, Lombardi G. Cella E, et al. Among authors: weller m. Cancer Treat Rev. 2024 Dec 21:102866. doi: 10.1016/j.ctrv.2024.102866. Online ahead of print. Cancer Treat Rev. 2024. PMID: 39709267 No abstract available.
1,712 results